换一批
换一批Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults.
第一作者：
Lisa A,Jackson
第一单位：
Group Health Research Institute, Seattle, Washington, United States. jackson.l@ghc.org
作者：
关键词
13-valent pneumococcal conjugate vaccine23-valent polysaccharide vaccine7-valent pneumococcal conjugate vaccineAEAdultCICRM197GMRGMTIPDLLOQLODOPAPCVPCV13PCV7PPSV23Pneumococcal conjugate vaccinePneumoniaRCDCSAEadverse eventconfidence intervalcross-reactive material 197geometric mean ratiogeometric mean titerinvasive pneumococcal diseaselimit of detectionlower limit of quantitationopsonophagocytic activitypneumococcal polysaccharide conjugate vaccinereverse cumulative distribution curveserious adverse event
主题词
抗体, 细菌(Antibodies, Bacterial);双盲法(Double-Blind Method);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);肺炎球菌菌苗(Pneumococcal Vaccines);肺炎, 肺炎球菌性(Pneumonia, Pneumococcal);多糖类, 细菌(Polysaccharides, Bacterial);肺炎链球菌(Streptococcus pneumoniae);美国(United States);疫苗, 结合(Vaccines, Conjugate)
DOI
10.1016/j.vaccine.2013.04.085
PMID
23688526
发布时间
2022-03-18
- 浏览109
Vaccine
3577-84页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
